CC
FOLD

Centiva Capital’s Amicus Therapeutics FOLD Stock Holding History

Centiva Capital’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,285
Closed -$137K – 1321
2021
Q3 		$137K Buy
+14,285
New +$146K 0.01% 986
2020
Q4 		– Sell
-18,639
Closed -$263K – 972
2020
Q3 		$263K Sell
18,639
-15,893
-46% -$232K 0.02% 508
2020
Q2 		$521K Buy
+34,532
New +$421K 0.03% 278
2020
Q1 		– Sell
-16,518
Closed -$161K – 719
2019
Q4 		$161K Buy
16,518
+5,490
+50% +$50.3K 0.01% 702
2019
Q3 		$88K Sell
11,028
-39
-0.4% -$423 0.01% 565
2019
Q2 		$138K Buy
+11,067
New +$140K 0.01% 360

Other funds holding FOLD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Centiva Capital's FOLD Position: Q4 2021 in Review

Centiva Capital sold out of Amicus Therapeutics (FOLD) in Q4 2021, closing a stake of 14,285 shares — an estimated $137K sold.

Centiva Capital first reported a position in FOLD in Q2 2019 and held it in 6 quarters. The position peaked at $521K in Q2 2020. 224 funds tracked by Wall St. Rank hold FOLD as of Q4 2021.

  • Centiva Capital reported no remaining Amicus Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Centiva Capital sold 14,285 Amicus Therapeutics shares in Q4 2021, an estimated $137K.
  • Centiva Capital first reported a position in Amicus Therapeutics in Q2 2019 and held it in 6 quarters.
  • Centiva Capital's Amicus Therapeutics position peaked at $521K in Q2 2020.
  • 224 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2021.

Based on Centiva Capital's 13F filing for Q4 2021, filed 14 Feb 2022.